※一部利用できない機能があります
| 1.
論文 |
論文
|
越野, 好文
概要:
金沢大学医学部神経精神医学教室
|
||||
| 2.
論文 |
論文
|
石崎, 純子 ; 横川, 弘一 ; 中島, 恵美 ; 古田, 壽一 ; 越野, 好文 ; 関, 秀俊 ; 谷口, 昂 ; 長谷川, 光広 ; 山下, 純宏 ; 市村, 藤雄
概要:
金沢大学大学院自然科学研究科分子作用学<br />金沢大学医学部附属病院薬剤部<br />金沢大学大学院医学系研究科<br />A fully automated enzyme immunoassay system, Omni (BIO-T
…
EK Co.) (ELISA system), using Markit-M Excegran and Markit-M Haloperidol (Dainippon Pharmaceutical Co.) was evaluated to determine the concentrations of zonisamide (ZNS) and haloperidol (HP) in human plasma. At first, the within-run (ZNS : n=8, HP : n=10) and the between-run (4 days) precisions of ZNS and HP were examined. The coefficient of the variations in both the within-run and the between-run previsions of HP were below 5.0 and 7.00/0, respectively. In contrast, the some values of ZNS were below 6.5 and 8.40/0, respectively. A good correlation was observed between this ELISA system and HPLC (r=0.917), which was used to determine the plasma ZNS concentration. In the case of HP, a good correlation was seen between this ELISA system and the manual ELISA method (r=0.978). This method was thus used to monitor the serum levels in patients receiving ZNS or HP therapy. The relationship was observed between the daily dose (mg/kg) and the plasma concentration of the trough level for ZNS and HP, respectively (r=0.750 p<0.001, r= 0.669 p<0.001). However, the ratio of the plasma concentration of ZNS and the daily dose increased significantly with aging.
続きを見る
|
||||
| 3.
論文 |
論文
|
田中, 啓一 ; 南部, 裕子 ; 和田, 有司 ; 太田, 和秀 ; 橋本, 琢磨 ; 越野, 好文
|
||||
| 4.
論文 |
論文
|
越野, 好文 ; 山口, 成良 ; 小山, 善子 ; 伊崎, 公徳
|
